|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:A2393 Batch: A239301
Lorvotuzumab (Anti-NCAM1 / CD56) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine. MW: 145.5 kD.
| CAS No. | 339306-30-8 |
|---|---|
| Formulation | 100 mM Pro-Ac, 20mM Arg, pH5.0 |
| Isotype | Human IgG1 |
| Source | CHO |
| Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
| Shipping | Shipped under low temperature conditions |
| Purity | 99% |
| Protein concentration | 8.29mg/ml |
| Endotoxin Level | <1EU/mg |
人間や獣医の診断であるか治療的な使用のためにでない。